These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11145762)

  • 1. Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).
    Abraham WT
    J Card Fail; 2000 Dec; 6(4):369-80. PubMed ID: 11145762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac resynchronization therapy for the management of chronic heart failure.
    Abraham WT
    Am Heart Hosp J; 2003; 1(1):55-61. PubMed ID: 15785177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac resynchronization therapy in advanced heart failure the multicenter InSync clinical study.
    Gras D; Leclercq C; Tang AS; Bucknall C; Luttikhuis HO; Kirstein-Pedersen A
    Eur J Heart Fail; 2002 Jun; 4(3):311-20. PubMed ID: 12034157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac resynchronization therapy in patients with heart failure and conduction abnormalities other than left bundle-branch block: analysis of the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).
    Aranda JM; Conti JB; Johnson JW; Petersen-Stejskal S; Curtis AB
    Clin Cardiol; 2004 Dec; 27(12):678-82. PubMed ID: 15628109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.
    Pires LA; Abraham WT; Young JB; Johnson KM;
    Am Heart J; 2006 Apr; 151(4):837-43. PubMed ID: 16569543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold M; Abraham WT; Daubert JC;
    Am Heart J; 2006 Feb; 151(2):288-94. PubMed ID: 16442890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
    Young JB; Abraham WT; Smith AL; Leon AR; Lieberman R; Wilkoff B; Canby RC; Schroeder JS; Liem LB; Hall S; Wheelan K;
    JAMA; 2003 May; 289(20):2685-94. PubMed ID: 12771115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac resynchronization therapy in patients with chronic heart failure: pathophysiology and current experience.
    Seidl K; Rameken M; Vater M; Senges J
    Am J Cardiovasc Drugs; 2002; 2(4):219-26. PubMed ID: 14727967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program.
    León AR; Abraham WT; Curtis AB; Daubert JP; Fisher WG; Gurley J; Hayes DL; Lieberman R; Petersen-Stejskal S; Wheelan K;
    J Am Coll Cardiol; 2005 Dec; 46(12):2348-56. PubMed ID: 16360070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronization therapy in patients with right bundle branch block: analysis of pooled data from the MIRACLE and Contak CD trials.
    Egoavil CA; Ho RT; Greenspon AJ; Pavri BB
    Heart Rhythm; 2005 Jun; 2(6):611-5. PubMed ID: 15922268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of cardiac resynchronization by sequential biventricular pacing and left ventricular pacing to simultaneous biventricular pacing: rationale and design of the DECREASE-HF clinical trial.
    De Lurgio DB; Foster E; Higginbotham MB; Larntz K; Saxon LA
    J Card Fail; 2005 Apr; 11(3):233-9. PubMed ID: 15812753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review: cardiac resynchronization in patients with symptomatic heart failure.
    McAlister FA; Ezekowitz JA; Wiebe N; Rowe B; Spooner C; Crumley E; Hartling L; Klassen T; Abraham W
    Ann Intern Med; 2004 Sep; 141(5):381-90. PubMed ID: 15353430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF study.
    Linde C; Curtis AB; Fonarow GC; Lee K; Little W; Tang A; Levya F; Momomura S; Manrodt C; Bergemann T; Cowie MR
    Int J Cardiol; 2016 Jan; 202():349-55. PubMed ID: 26426276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac resynchronization therapy for heart failure].
    Achilli A; Patruno N; Pontillo D; Sassara M
    Ital Heart J Suppl; 2004 Jun; 5(6):445-56. PubMed ID: 15471149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced ventricular volumes and improved systolic function with cardiac resynchronization therapy: a randomized trial comparing simultaneous biventricular pacing, sequential biventricular pacing, and left ventricular pacing.
    Rao RK; Kumar UN; Schafer J; Viloria E; De Lurgio D; Foster E
    Circulation; 2007 Apr; 115(16):2136-44. PubMed ID: 17420340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. His-bundle pacing versus biventricular pacing in cardiac resynchronization therapy patients: A crossover design comparison.
    Lustgarten DL; Crespo EM; Arkhipova-Jenkins I; Lobel R; Winget J; Koehler J; Liberman E; Sheldon T
    Heart Rhythm; 2015 Jul; 12(7):1548-57. PubMed ID: 25828601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure.
    León AR; Abraham WT; Brozena S; Daubert JP; Fisher WG; Gurley JC; Liang CS; Wong G;
    J Am Coll Cardiol; 2005 Dec; 46(12):2298-304. PubMed ID: 16360062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.